Loading clinical trials...

Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDPhase 2NCT00002993

Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial...

Lead sponsor: Gynecologic Oncology Group•54 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 1

A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors

NCT06926283 · Prostate Cancer, Other Solid Tumors, and more

RECRUITING

Familial Investigations of Childhood Cancer Predisposition

NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more

RECRUITINGPhase 2

Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part Sarcoma

NCT07548177 · Alveolar Soft Part Sarcoma

RECRUITINGPhase 3

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

NCT06422806 · Metastatic Dedifferentiated Liposarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma, and more

RECRUITINGPhase 2

Ph 2 Elacestrant in ER Positive Uterine Sarcomas

NCT07467772 · Uterine Sarcoma, Uterine Leiomyosarcoma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 9, 2013Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2

Enrollment30

Start dateAug 1997

Last updatedJul 9, 2013

Condition

Sarcoma

Locations shown

University of Alabama Comprehensive Cancer Center

Birmingham, Alabama

USC/Norris Comprehensive Cancer Center

Los Angeles, California

Jonsson Comprehensive Cancer Center, UCLA

Los Angeles, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 9, 2013Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions